Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Alzheimer Research

• Publication date

  2011-07-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156720511796391926PMID 21605054PMCID PMC3518784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression.

  2011cited by this paper
• Alzheimer's disease.

  2011influential reference
• Alzheimer's disease.

  2010cited by this paper
• DHA may prevent age-related dementia.

  2010cited by this paper
• Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism.

  2010cited by this paper
• Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil.

  2010cited by this paper
• Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women

  2010cited by this paper
• Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.

  2010cited by this paper
• Association of C-reactive protein with cognitive impairment.

  2010cited by this paper
• Fatty Acid Composition of Frontal, Temporal and Parietal Neocortex in the Normal Human Brain and in Alzheimer’s Disease

  2010cited by this paper
• Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

  2010cited by this paper
• Beneficial effects of docosahexaenoic acid on cognition in age‐related cognitive decline

  2010cited by this paper
• Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.

  2009cited by this paper
• Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

  2009cited by this paper
• Mechanisms of obesity and related pathologies: Role of apolipoprotein E in the development of obesity

  2009cited by this paper
• Central obesity and increased risk of dementia more than three decades later.

  2009cited by this paper
• Nutrition, Brain Aging, and Neurodegeneration

  2009cited by this paper
• Metabolic response to a ketogenic breakfast in the healthy elderly

  2009cited by this paper
• Total cholesterol and oxysterols: early markers for cognitive decline in elderly?

  2009cited by this paper
• Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men.

  2009cited by this paper
• Diet quality is associated with better cognitive test performance among aging men and women.

  2009cited by this paper
• Systemic inflammation and disease progression in Alzheimer disease

  2009cited by this paper
• Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

  2009cited by this paper
• Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging.

  2009cited by this paper
• Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia

  2009cited by this paper
• Dietary patterns and risk of dementia: The Three-City cohort study

  2009cited by this paper
• Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

  2009cited by this paper
• Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.

  2009cited by this paper
• Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

  2009cited by this paper
• Resolving the relationship between ApolipoproteinE and depression.

  2009cited by this paper
• Early intervention in Alzheimer disease

  2009cited by this paper
• Omega‐3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega‐3 Alzheimer's Disease Study

  2009cited by this paper
• Serum cholesterol, apolipoprotein E genotype and depressive symptoms in elderly European men: the FINE study.

  2009cited by this paper
• Changing perspectives regarding late-life dementia

  2009influential reference
• The role of apolipoprotein E in Alzheimer's disease.

  2009cited by this paper
• Selenium level is associated with apoE ε4 in rural elderly Chinese

  2009cited by this paper
• Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity.

  2009cited by this paper
• Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging.

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Effects of Omega-3 Fatty Acids on Inflammatory Markers in Cerebrospinal Fluid and Plasma in Alzheimer’s Disease: The OmegAD Study

  2009cited by this paper
• Fish, docosahexaenoic acid and Alzheimer's disease.

  2009cited by this paper
• Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE ɛ4 but not by the common PPAR-α L162V polymorphism in men

  2009cited by this paper
• Intakes of (n-3) fatty acids and fatty fish are not associated with cognitive performance and 6-year cognitive change in men participating in the Veterans Affairs Normative Aging Study.

  2009cited by this paper
• Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• ApoE4-dependent Aβ-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum

  2009cited by this paper
• Central obesity and increased risk of dementia more than three decades later.

  2009cited by this paper
• Total and regional adiposity and cognitive change in older adults: The Health, Aging and Body Composition (ABC) study.

  2009cited by this paper
• Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later

  2009cited by this paper
• Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

  2009cited by this paper
• Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study

  2008cited by this paper
• Contributions (in 2005) of marine and fresh water products (finfish and shellfish, seafood, wild and farmed) to the French dietary intakes of vitamins D and B12, selenium, iodine and docosahexaenoic acid: impact on public health

  2008cited by this paper
• Docosahexaenoic acid and the aging brain.

  2008cited by this paper
• Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms

  2008cited by this paper
• NSAID use and dementia risk in the Cardiovascular Health Study*

  2008cited by this paper
• Central obesity and increased risk of dementia more than three decades later

  2008cited by this paper
• The opposing effects of n-3 and n-6 fatty acids.

  2008cited by this paper
• Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta‐analysis

  2008cited by this paper
• No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

  2008cited by this paper
• Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk.

  2008cited by this paper
• Arachidonic acid and the brain.

  2008cited by this paper
• Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study.

  2008cited by this paper
• Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.

  2008cited by this paper
• Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.

  2008cited by this paper
• n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood

  2008cited by this paper
• Effect of fish oil on cognitive performance in older subjects

  2008cited by this paper
• Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.

  2008cited by this paper
• Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele.

  2008cited by this paper
• Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men

  2008cited by this paper
• Homocysteine and cognitive performance: modification by the ApoE genotype.

  2008cited by this paper
• Late‐Life Body Mass Index and Dementia Incidence: Nine‐Year Follow‐Up Data from the Kungsholmen Project

  2008cited by this paper
• Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease.

  2008cited by this paper
• Bioactive lipids in metabolic syndrome.

  2008cited by this paper
• Fatty acids, lipid metabolism and Alzheimer pathology.

  2008influential reference
• Obesity and hypertriglyceridemia produce cognitive impairment.

  2008cited by this paper
• The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.

  2008cited by this paper
• Impact of apoE genotype on oxidative stress, inflammation and disease risk.

  2008influential reference
• n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood.

  2008cited by this paper
• Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women.

  2008influential reference
• Depressive symptoms, vascular risk factors, and Alzheimer's disease

  2008cited by this paper
• Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease.

  2007cited by this paper
• Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study.

  2007cited by this paper
• Low vitamin B-12 status and risk of cognitive decline in older adults.

  2007cited by this paper
• Dietary patterns and risk of dementia

  2007cited by this paper
• Role of Liver and Plasma Lipoproteins in Selective Transport of n-3 Fatty Acids to Tissues: A Comparative Study of 14C-DHA and 3H-Oleic Acid Tracers

  2007cited by this paper
• Brain Uptake and Utilization of Fatty Acids, Lipids and Lipoproteins: Application to Neurological Disorders

  2007cited by this paper
• Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities

  2007cited by this paper
• Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

  2007cited by this paper
• A Model for Fatty Acid Transport into the Brain

  2007cited by this paper
• The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype

  2007cited by this paper
• ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation

  2007cited by this paper
• A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.

  2007cited by this paper
• Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements.

  2007cited by this paper
• Serum cholesterol changes after midlife and late-life cognition

  2007cited by this paper
• A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.

  2007cited by this paper
• Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper.

  2007cited by this paper
• Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients.

  2007cited by this paper
• Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging.

  2007cited by this paper
• Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

  2007cited by this paper
• Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging.

  2006cited by this paper

• Fast autoregressive model for multivariate dependent outcomes with application to lipidomics analysis for Alzheimer's disease and APOE-ε4

  2025cites this paper
• Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study

  2025cites this paper
• Polyunsaturated fatty acids, APOE genotypes, and dementia incidence and mortality among hypertensive adults

  2025cites this paper
• Influence of Post‐Harvest Treatments on Antioxidant Potential and Metabolomics Profile of Coffee Beans

  2025cites this paper
• Anti-aging natural supplements: the main players in promoting healthy lifespan.

  2024cites this paper
• Aging, sex, metabolic and life experience factors: contributions to neuro-inflammaging in Alzheimer's disease research.

  2024cites this paper
• APOE genotype dictates lipidomic signatures in primary human hepatocytes

  2024cites this paper
• Alzheimer's Disease Prevention and Treatment Based on Population-Based Approaches.

  2024cites this paper
• Sex, Body Mass Index, and APOE4 Increase Plasma Phospholipid–Eicosapentaenoic Acid Response During an ω-3 Fatty Acid Supplementation: A Secondary Analysis

  2024cites this paper
• The effects of APOE4 and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age‐ and sex‐dependent

  2024cites this paper
• Fish consumption, cognitive impairment and dementia: an updated dose-response meta-analysis of observational studies

  2024cites this paper
• Analyzing eight Turkish macroalgae: Fatty acids, proteins, and in silico biological activity profiles

  2024cites this paper
• Apolipoprotein E and its association with cognitive change and modification of treatment effects of vitamin D3 and omega-3s on cognitive change: results from the in-clinic subset of a randomized clinical trial.

  2023cites this paper
• Computational analysis of Alzheimer's disease-associated missense SNPs to understand underlying molecular mechanisms and identify diagnostic biomarkers.

  2023cites this paper
• The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from perspective cohort studies of supplementation, dietary intake, and blood markers.

  2023cites this paper
• Detection of early Alzheimer's disease‐like molecular alterations in a mouse model expressing human ApoE4

  2023cites this paper
• Effect of Mediterranean Dietary Pattern on Cognitive Status in Community-Dwelling Older Adults

  2023cites this paper
• Red Blood Cell Fatty Acid Profiles Are Significantly Altered in South Australian Mild Cognitive Impairment and Alzheimer’s Disease Cases Compared to Matched Controls

  2023cites this paper
• Mózg na talerzu, czyli o wpływie diety na rozwój choroby Alzheimera

  2023cites this paper
• APOE alleles modulate associations of plasma metabolites with variants from multiple genes on chromosome 19q13.3

  2022cites this paper
• Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics

  2022cites this paper
• The effects of docosahexaenoic acid supplementation on cognition and well‐being in mild cognitive impairment: A 12‐month randomised controlled trial

  2022cites this paper
• Personalized nutrition: A review of genotype-based nutritional supplementation

  2022cites this paper
• Palmitic Acid and Oleic Acid Differently Modulate TLR2-Mediated Inflammatory Responses in Microglia and Macrophages

  2022cites this paper
• Characterization and Optimization of Culture Conditions for Aurantiochytrium sp. SC145 Isolated from Sand Cay (Son Ca) Island, Vietnam, and Antioxidative and Neuroprotective Activities of Its Polyunsaturated Fatty Acid Mixture

  2022cites this paper
• Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer’s Dementia in the Oldest Old

  2021cites this paper
• High Glycemic Load Is Associated with Cognitive Decline in Apolipoprotein E epsilon4 Allele Carriers

  2021cites this paper
• Interactions between dietary patterns and genetic factors in relation to incident dementia among 70-year-olds

  2021cites this paper
• Fish, n-3 fatty acids, cognition and dementia risk: not just a fishy tale

  2021cites this paper
• Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition.

  2021cites this paper
• APOE Genotype and Alzheimer's Disease: The Influence of Lifestyle and Environmental Factors.

  2021cites this paper
• Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies.

  2021cites this paper
• Association of Life's Simple 7 with incident dementia and its modification by the apolipoprotein E genotype

  2021cites this paper
• ω-3 fatty acids and their interactions.

  2021cites this paper
• Analysis of plants lipids

  2020cites this paper
• Targeting Lifestyle Behavior to Improve Brain Health: User-Experiences of an Online Program for Individuals with Subjective Cognitive Decline

  2020cites this paper
• Healthy Brain, Healthy Life: a review of diet and exercise interventions to promote brain health and reduce Alzheimer's disease risk.

  2020cites this paper
• Cognitive Function and Amyloid Marker in Frail Older Adults: The Cogfrail Cohort Study

  2020cites this paper
• Metabolite profile of whole grain ting (a Southern African fermented product) obtained using two strains of Lactobacillus fermentum

  2020cites this paper
• High Glycemic Load Is Associated with Cognitive Decline in Apolipoprotein E ε4 Allele Carriers

  2020cites this paper
• Midlife Dietary Intakes of Monounsaturated Acids, n-6 Polyunsaturated Acids, and Plant-Based Fat Are Inversely Associated with Risk of Cognitive Impairment in Older Singapore Chinese Adults.

  2019cites this paper
• Aging membranes: Unexplored functions for lipids in the lifespan of the central nervous system.

  2019cites this paper
• Effects of apolipoprotein E on nutritional metabolism in dementia

  2019cites this paper
• Diet and Alzheimer's dementia - Nutritional approach to modulate inflammation.

  2019cites this paper
• Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health

  2019cites this paper
• Functional Food Consumption and Its Physiological Effects

  2019cites this paper
• Omega-3 PUFA metabolism and brain modifications during aging.

  2019cites this paper
• Nutrients in Alzheimer’s Disease: The Interaction of Diet, Drugs and Disease

  2019cites this paper
• Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status

  2019cites this paper
• Fish Intake, Genetic Predisposition to Alzheimer Disease, and Decline in Global Cognition and Memory in 5 Cohorts of Older Persons

  2018cites this paper
• Healthy Dietary Changes in Midlife Are Associated with Reduced Dementia Risk Later in Life

  2018cites this paper
• Unsaturated Fatty Acid Intakes During Midlife Are Positively Associated with Later Cognitive Function in Older Adults with Modulating Effects of Antioxidant Supplementation.

  2018cites this paper
• Population-Based Approaches to Alzheimer's Disease Prevention.

  2018cites this paper
• The Role of Tau Protein in Diseases

  2018cites this paper
• Tropical Epidemiology: Nutritional Factors

  2018cites this paper
• APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality

  2018cites this paper
• Prospective Associations between Single Foods, Alzheimer’s Dementia and Memory Decline in the Elderly

  2018cites this paper
• Biomarkers for Alzheimer’s Disease Drug Development

  2018cites this paper
• Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

  2017cites this paper
• Omega-3 polyunsaturated fatty acids and brain health: Preclinical evidence for the prevention of neurodegenerative diseases

  2017cites this paper
• Obesity Accelerates Alzheimer-Related Pathology in APOE4 but not APOE3 Mice

  2017cites this paper
• Use of Phytochemicals against Neuroinflammation

  2017cites this paper
• Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response

  2017cites this paper
• Nutrition for the ageing brain: Towards evidence for an optimal diet.

  2017cites this paper
• Nutrition and AGE-ing: Focusing on Alzheimer's Disease

  2017cites this paper
• The Role of Omega-3 Fatty Acids in Reverse Cholesterol Transport: A Review

  2017cites this paper
• Impact and Application of Nutraceuticals on Inflammation-Induced Colorectal Cancer Development

  2017cites this paper
• APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease

  2017cites this paper
• Palmitic Acid-BSA enhances Amyloid-β production through GPR40-mediated dual pathways in neuronal cells: Involvement of the Akt/mTOR/HIF-1α and Akt/NF-κB pathways

  2017cites this paper
• MARINE ALGAE AS A SOURCE OF PREVENTION AND RELIEF IN THOSE WITH DEPRESSION AND DEMENTIA

  2017cites this paper
• Metabolic characterization of grapevine leaves: first clues towards biomarkers discovery

  2016cites this paper
• Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores

  2016influential citation
• Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease

  2016cites this paper
• Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment

  2016cites this paper
• Long-chain omega3 polyunsaturated fatty acids and cognition in older people: interaction with APOE genotype

  2016cites this paper
• Omega-3 Fatty Acids and their Role in Central Nervous System - A Review.

  2016cites this paper
• The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.

  2016cites this paper
• Fish and Fish Oil for the Aging Brain

  2016cites this paper
• REVIEWS: CURRENT TOPICS The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease

  2016cites this paper
• utrition for the ageing brain: Towards evidence for an optimal diet

  2016cites this paper
• Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults.

  2016cites this paper
• , BrainMercury Level , and APOE ε 4 StatusWithBrainNeuropathology inOlderAdults

  2016cites this paper
• N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease

  2015cites this paper
• Docosahexaenoic acid promotes micron scale liquid-ordered domains. A comparison study of docosahexaenoic versus oleic acid containing phosphatidylcholine in raft-like mixtures.

  2015cites this paper
• Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment.

  2015cites this paper
• ω‐3 Supplementation increases amyloid‐β phagocytosis and resolvin D1 in patients with minor cognitive impairment

  2015cites this paper
• The Impact of High Saturated Fat and High Glycemic Index Foods on Cognitive Function and Alzheimer’s Disease Biomarkers: Does a Typical Western Diet Cause Alzheimer’s Disease?

  2015cites this paper
• Challenges to determining whether DHA can protect against age-related cognitive decline

  2015cites this paper
• Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration

  2015cites this paper
• Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment

  2015cites this paper
• Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.

  2015cites this paper
• The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders

  2015cites this paper
• Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment

  2015cites this paper
• Le régime méditerranéen peut-il ralentir le déclin cognitif lié à l’âge ?

  2015cites this paper
• Mechanisms of Docosahexaenoic Acid (DHA) in Neurodevelopment and Brain Protection

  2015cites this paper
• Chapter 64 – 1α,25-Dihydroxyvitamin D3 and Resolvins Improve Immunity to Amyloid-β in Patients with Alzheimer’s Disease

  2015cites this paper
• Dietary fat composition and dementia risk.

  2014cites this paper
• Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2

  2014cites this paper
• Apolipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice.

  2014cites this paper
• n-3 LCPUFA improves cognition: the young, the old and the sick.

  2014cites this paper